• SNS-032 (BMS-387032): CDK Inhibition for Cancer and Host-Pat

  2026-05-21

  Discover the advanced utility of SNS-032 (BMS-387032) as a potent selective CDK inhibitor for cancer research and host-pathogen interface studies. Explore its unique mechanisms, protocol guidance, and translational insights in oncology and virology.

• IEM 1460: Advancing AMPA Receptor Blockade Beyond Protocols

  2026-05-21

  Explore IEM 1460 as a next-generation AMPA receptor blocker, with in-depth analysis on its neuroprotective mechanisms and unique applications in excitotoxicity and synaptic research. Discover how this compound elevates assay design and interpretation beyond standard protocols.

• Salinomycin in HCC Research: Reproducible Anti-Cancer Protoc

  2026-05-20

  This article addresses common laboratory challenges in hepatocellular carcinoma (HCC) research and highlights how Salinomycin (SKU A3785) provides evidence-backed, reproducible solutions for cell viability and apoptosis assays. Scenario-driven Q&As guide researchers through mechanistic principles, protocol optimization, and vendor reliability, with direct links to validated product information.

• Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Actionab

  2026-05-20

  Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) prevents protein degradation during extraction by inhibiting a broad range of proteases while remaining mass spectrometry compatible. Its AEBSF-free formula is ideal for workflows requiring accurate MS analysis, but it is not suitable where AEBSF or DMSO incompatibility is a concern.

• JNJ-10198409: Precision Platelet-Derived Growth Factor Recep

  2026-05-19

  JNJ-10198409 stands out as a nanomolar ATP-competitive inhibitor for high-precision modulation of PDGF-BB signaling in angiogenesis and tumor growth assays. Its versatility in workflow integration and robust data-backed performance empower cancer biology and fibrotic disorder research to new technical heights.

• SHC-1 Inhibition Elevates CFTR Surface Abundance in Epitheli

  2026-05-19

  This study elucidates how SHC-1 inhibitors regulate the abundance of CFTR chloride channels at the plasma membrane in diverse epithelial models. By dissecting the MAPK/SHC-1 pathway, the authors reveal cell-type-specific mechanisms controlling CFTR trafficking, with implications for cystic fibrosis and secretory disease research.

• Nitrocefin: Chromogenic Cephalosporin Substrate in Resistanc

  2026-05-18

  Nitrocefin, a leading chromogenic cephalosporin substrate, transforms β-lactamase activity detection through rapid, visual colorimetric assays. Discover its workflow flexibility, troubleshooting strategies, and unique advantages in advanced antibiotic resistance profiling and β-lactamase inhibitor screening.

• ECL Chemiluminescent Substrate Detection Kit: Mechanism, Sen

  2026-05-18

  Discover the scientific foundation and unique analytical power of the ECL Chemiluminescent Substrate Detection Kit in sensitive Western blot and immunoassay workflows. This article reveals deeper mechanistic and application insights not covered in standard protocol guides.

• Epigenetic Predictors and Advanced Assays with PD 173074

  2026-05-17

  Explore how PD 173074 enables precision FGFR signaling pathway inhibition and how epigenetic biomarkers drive assay optimization. This in-depth article reveals new research perspectives and practical guidance for advancing cancer studies with PD-173074.

• Oltipraz in Redox Biology: Precision Applications Beyond Nrf

  2026-05-16

  Explore how Oltipraz, a potent 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, enables advanced chemopreventive and redox research. This article reveals mechanistic insights and practical guidance distinct from protocol-focused coverage.

• ECL Chemiluminescent Substrate Detection Kit: Workflow & Inn

  2026-05-15

  The ECL Chemiluminescent Substrate Detection Kit from APExBIO delivers ultrasensitive, reproducible Western blot and immunoassay results, empowering advanced protein and nucleic acid detection. This guide presents actionable protocol enhancements, troubleshooting insights, and lessons drawn from integrated multi-omics research on chronic migraine.

• hiPSC-Derived Intestinal Organoids in Pharmacokinetic Modeli

  2026-05-15

  This study introduces a streamlined protocol for generating human pluripotent stem cell-derived intestinal organoids suitable for pharmacokinetic research. The approach addresses key limitations in current in vitro models, offering improved physiological relevance for drug absorption and metabolism studies.

• 4-Phenylbutyric Acid: Optimizing ER Stress Pathway Assays

  2026-05-14

  4-Phenylbutyric acid (4-PBA) is a gold-standard chemical chaperone for dissecting endoplasmic reticulum (ER) stress and related cell death mechanisms. This guide offers actionable protocols, troubleshooting insights, and the latest experimental innovations—translating bench research into robust workflows for disease modeling and therapeutic discovery.

• Cyclic di-GMP as an Antitoxin: Regulating Biofilm Persistenc

  2026-05-14

  Liao et al. (2024) discovered that cyclic di-GMP acts as an antitoxin in a novel toxin-antitoxin system, controlling both genome stability and antibiotic persistence in bacterial biofilms. This finding reframes the molecular basis of bacterial persistence, with significant implications for infection biology and the development of anti-biofilm strategies.

• Actin–Myosin II Network Regulates Duck Enteritis Virus Proli

  2026-05-13

  This study identifies host cytoskeletal proteins interacting with the duck enteritis virus VP26 protein, revealing that the actin–myosin II network is essential for efficient viral replication. Chemical disruption of actin assembly, including with Latrunculin A, significantly reduces viral titers, providing mechanistic insights and practical targets for virology research.

16498 records 2/1100 page Previous Next 12345 下5页 Last page